Covid-19 Impact on Global Antiviral Oral Liquid Market Size, Status and Forecast 2020-2026

June 2020 | 129 pages | ID: CBC9479C1C9AEN
QYResearch

Abstracts

Antiviral Oral Liquid market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antiviral Oral Liquid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Antiviral Oral Liquid market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Antiviral Oral Liquid industry.
The key players covered in this study

• Pfizer
• Roche
• Novartis
• Merck
• GlaxoSmithKline
• Johnson & Johnson
• AbbVie
• Sanofi
• Bristol-Myers Squibb
• AstraZeneca
• Eli Lilly
• Novo Nordisk
• Amgen
• Gilead Sciences
• CSL
• Takeda Pharmaceuticals
• Bayer
• Celgene
• Merck KGaA
• Allergan

Market segment by Type, the product can be split into

• Syrup
• Oral suspension
• Oral solution
• Oral drop
• Oral emulsion
• Mixture

Market segment by Application, split into

• Adults
• Children

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Antiviral Oral Liquid status, future forecast, growth opportunity, key market and key players.
• To present the Antiviral Oral Liquid development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Antiviral Oral Liquid are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Antiviral Oral Liquid Revenue
1.4 Covid-19 Implications on Market by Type
  1.4.1 Global Antiviral Oral Liquid Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Syrup
  1.4.3 Oral suspension
  1.4.4 Oral solution
  1.4.5 Oral drop
  1.4.6 Oral emulsion
  1.4.7 Mixture
1.5 Market by Application
  1.5.1 Global Antiviral Oral Liquid Market Share by Application: 2020 VS 2026
  1.5.2 Adults
  1.5.3 Children
1.6 Coronavirus Disease 2019 (Covid-19): Antiviral Oral Liquid Industry Impact
  1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  1.6.2 Covid-19 Impact: Commodity Prices Indices
  1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Covid-19 Implications on Global Antiviral Oral Liquid Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Antiviral Oral Liquid Growth Trends by Regions
  2.2.1 Antiviral Oral Liquid Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Antiviral Oral Liquid Historic Market Share by Regions (2015-2020)
  2.2.3 Antiviral Oral Liquid Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Antiviral Oral Liquid Market Growth Strategy
  2.3.6 Primary Interviews with Key Antiviral Oral Liquid Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Antiviral Oral Liquid Players by Market Size
  3.1.1 Global Top Antiviral Oral Liquid Players by Revenue (2015-2020)
  3.1.2 Global Antiviral Oral Liquid Revenue Market Share by Players (2015-2020)
  3.1.3 Global Antiviral Oral Liquid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Antiviral Oral Liquid Market Concentration Ratio
  3.2.1 Global Antiviral Oral Liquid Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Antiviral Oral Liquid Revenue in 2019
3.3 Antiviral Oral Liquid Key Players Head office and Area Served
3.4 Key Players Antiviral Oral Liquid Product Solution and Service
3.5 Date of Enter into Antiviral Oral Liquid Market
3.6 Mergers & Acquisitions, Expansion Plans

4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)

4.1 Global Antiviral Oral Liquid Historic Market Size by Type (2015-2020)
4.2 Global Antiviral Oral Liquid Forecasted Market Size by Type (2021-2026)

5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Antiviral Oral Liquid Market Size by Application (2015-2020)
5.2 Global Antiviral Oral Liquid Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA IMPACT OF COVID-19

6.1 North America Antiviral Oral Liquid Market Size (2015-2020)
6.2 Antiviral Oral Liquid Key Players in North America (2019-2020)
6.3 North America Antiviral Oral Liquid Market Size by Type (2015-2020)
6.4 North America Antiviral Oral Liquid Market Size by Application (2015-2020)

7 EUROPE IMPACT OF COVID-19

7.1 Europe Antiviral Oral Liquid Market Size (2015-2020)
7.2 Antiviral Oral Liquid Key Players in Europe (2019-2020)
7.3 Europe Antiviral Oral Liquid Market Size by Type (2015-2020)
7.4 Europe Antiviral Oral Liquid Market Size by Application (2015-2020)

8 CHINA IMPACT OF COVID-19

8.1 China Antiviral Oral Liquid Market Size (2015-2020)
8.2 Antiviral Oral Liquid Key Players in China (2019-2020)
8.3 China Antiviral Oral Liquid Market Size by Type (2015-2020)
8.4 China Antiviral Oral Liquid Market Size by Application (2015-2020)

9 JAPAN IMPACT OF COVID-19

9.1 Japan Antiviral Oral Liquid Market Size (2015-2020)
9.2 Antiviral Oral Liquid Key Players in Japan (2019-2020)
9.3 Japan Antiviral Oral Liquid Market Size by Type (2015-2020)
9.4 Japan Antiviral Oral Liquid Market Size by Application (2015-2020)

10 SOUTHEAST ASIA IMPACT OF COVID-19

10.1 Southeast Asia Antiviral Oral Liquid Market Size (2015-2020)
10.2 Antiviral Oral Liquid Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Antiviral Oral Liquid Market Size by Type (2015-2020)
10.4 Southeast Asia Antiviral Oral Liquid Market Size by Application (2015-2020)

11 INDIA IMPACT OF COVID-19

11.1 India Antiviral Oral Liquid Market Size (2015-2020)
11.2 Antiviral Oral Liquid Key Players in India (2019-2020)
11.3 India Antiviral Oral Liquid Market Size by Type (2015-2020)
11.4 India Antiviral Oral Liquid Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA IMPACT OF COVID-19

12.1 Central & South America Antiviral Oral Liquid Market Size (2015-2020)
12.2 Antiviral Oral Liquid Key Players in Central & South America (2019-2020)
12.3 Central & South America Antiviral Oral Liquid Market Size by Type (2015-2020)
12.4 Central & South America Antiviral Oral Liquid Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Antiviral Oral Liquid Introduction
  13.1.4 Pfizer Revenue in Antiviral Oral Liquid Business (2015-2020))
  13.1.5 Pfizer Recent Development and Reaction to COVID-19
13.2 Roche
  13.2.1 Roche Company Details
  13.2.2 Roche Business Overview and Its Total Revenue
  13.2.3 Roche Antiviral Oral Liquid Introduction
  13.2.4 Roche Revenue in Antiviral Oral Liquid Business (2015-2020)
  13.2.5 Roche Recent Development and Reaction to COVID-19
13.3 Novartis
  13.3.1 Novartis Company Details
  13.3.2 Novartis Business Overview and Its Total Revenue
  13.3.3 Novartis Antiviral Oral Liquid Introduction
  13.3.4 Novartis Revenue in Antiviral Oral Liquid Business (2015-2020)
  13.3.5 Novartis Recent Development and Reaction to COVID-19
13.4 Merck
  13.4.1 Merck Company Details
  13.4.2 Merck Business Overview and Its Total Revenue
  13.4.3 Merck Antiviral Oral Liquid Introduction
  13.4.4 Merck Revenue in Antiviral Oral Liquid Business (2015-2020)
  13.4.5 Merck Recent Development and Reaction to COVID-19
13.5 GlaxoSmithKline
  13.5.1 GlaxoSmithKline Company Details
  13.5.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.5.3 GlaxoSmithKline Antiviral Oral Liquid Introduction
  13.5.4 GlaxoSmithKline Revenue in Antiviral Oral Liquid Business (2015-2020)
  13.5.5 GlaxoSmithKline Recent Development and Reaction to COVID-19
13.6 Johnson & Johnson
  13.6.1 Johnson & Johnson Company Details
  13.6.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.6.3 Johnson & Johnson Antiviral Oral Liquid Introduction
  13.6.4 Johnson & Johnson Revenue in Antiviral Oral Liquid Business (2015-2020)
  13.6.5 Johnson & Johnson Recent Development and Reaction to COVID-19
13.7 AbbVie
  13.7.1 AbbVie Company Details
  13.7.2 AbbVie Business Overview and Its Total Revenue
  13.7.3 AbbVie Antiviral Oral Liquid Introduction
  13.7.4 AbbVie Revenue in Antiviral Oral Liquid Business (2015-2020)
  13.7.5 AbbVie Recent Development and Reaction to COVID-19
13.8 Sanofi
  13.8.1 Sanofi Company Details
  13.8.2 Sanofi Business Overview and Its Total Revenue
  13.8.3 Sanofi Antiviral Oral Liquid Introduction
  13.8.4 Sanofi Revenue in Antiviral Oral Liquid Business (2015-2020)
  13.8.5 Sanofi Recent Development and Reaction to COVID-19
13.9 Bristol-Myers Squibb
  13.9.1 Bristol-Myers Squibb Company Details
  13.9.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  13.9.3 Bristol-Myers Squibb Antiviral Oral Liquid Introduction
  13.9.4 Bristol-Myers Squibb Revenue in Antiviral Oral Liquid Business (2015-2020)
  13.9.5 Bristol-Myers Squibb Recent Development and Reaction to COVID-19
13.10 AstraZeneca
  13.10.1 AstraZeneca Company Details
  13.10.2 AstraZeneca Business Overview and Its Total Revenue
  13.10.3 AstraZeneca Antiviral Oral Liquid Introduction
  13.10.4 AstraZeneca Revenue in Antiviral Oral Liquid Business (2015-2020)
  13.10.5 AstraZeneca Recent Development and Reaction to COVID-19
13.11 Eli Lilly
  10.11.1 Eli Lilly Company Details
  10.11.2 Eli Lilly Business Overview and Its Total Revenue
  10.11.3 Eli Lilly Antiviral Oral Liquid Introduction
  10.11.4 Eli Lilly Revenue in Antiviral Oral Liquid Business (2015-2020)
  10.11.5 Eli Lilly Recent Development and Reaction to COVID-19
13.12 Novo Nordisk
  10.12.1 Novo Nordisk Company Details
  10.12.2 Novo Nordisk Business Overview and Its Total Revenue
  10.12.3 Novo Nordisk Antiviral Oral Liquid Introduction
  10.12.4 Novo Nordisk Revenue in Antiviral Oral Liquid Business (2015-2020)
  10.12.5 Novo Nordisk Recent Development and Reaction to COVID-19
13.13 Amgen
  10.13.1 Amgen Company Details
  10.13.2 Amgen Business Overview and Its Total Revenue
  10.13.3 Amgen Antiviral Oral Liquid Introduction
  10.13.4 Amgen Revenue in Antiviral Oral Liquid Business (2015-2020)
  10.13.5 Amgen Recent Development and Reaction to COVID-19
13.14 Gilead Sciences
  10.14.1 Gilead Sciences Company Details
  10.14.2 Gilead Sciences Business Overview and Its Total Revenue
  10.14.3 Gilead Sciences Antiviral Oral Liquid Introduction
  10.14.4 Gilead Sciences Revenue in Antiviral Oral Liquid Business (2015-2020)
  10.14.5 Gilead Sciences Recent Development and Reaction to COVID-19
13.15 CSL
  10.15.1 CSL Company Details
  10.15.2 CSL Business Overview and Its Total Revenue
  10.15.3 CSL Antiviral Oral Liquid Introduction
  10.15.4 CSL Revenue in Antiviral Oral Liquid Business (2015-2020)
  10.15.5 CSL Recent Development and Reaction to COVID-19
13.16 Takeda Pharmaceuticals
  10.16.1 Takeda Pharmaceuticals Company Details
  10.16.2 Takeda Pharmaceuticals Business Overview and Its Total Revenue
  10.16.3 Takeda Pharmaceuticals Antiviral Oral Liquid Introduction
  10.16.4 Takeda Pharmaceuticals Revenue in Antiviral Oral Liquid Business (2015-2020)
  10.16.5 Takeda Pharmaceuticals Recent Development and Reaction to COVID-19
13.17 Bayer
  10.17.1 Bayer Company Details
  10.17.2 Bayer Business Overview and Its Total Revenue
  10.17.3 Bayer Antiviral Oral Liquid Introduction
  10.17.4 Bayer Revenue in Antiviral Oral Liquid Business (2015-2020)
  10.17.5 Bayer Recent Development and Reaction to COVID-19
13.18 Celgene
  10.18.1 Celgene Company Details
  10.18.2 Celgene Business Overview and Its Total Revenue
  10.18.3 Celgene Antiviral Oral Liquid Introduction
  10.18.4 Celgene Revenue in Antiviral Oral Liquid Business (2015-2020)
  10.18.5 Celgene Recent Development and Reaction to COVID-19
13.19 Merck KGaA
  10.19.1 Merck KGaA Company Details
  10.19.2 Merck KGaA Business Overview and Its Total Revenue
  10.19.3 Merck KGaA Antiviral Oral Liquid Introduction
  10.19.4 Merck KGaA Revenue in Antiviral Oral Liquid Business (2015-2020)
  10.19.5 Merck KGaA Recent Development and Reaction to COVID-19
13.20 Allergan
  10.20.1 Allergan Company Details
  10.20.2 Allergan Business Overview and Its Total Revenue
  10.20.3 Allergan Antiviral Oral Liquid Introduction
  10.20.4 Allergan Revenue in Antiviral Oral Liquid Business (2015-2020)
  10.20.5 Allergan Recent Development and Reaction to COVID-19

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Antiviral Oral Liquid Key Market Segments
Table 2. Key Players Covered: Ranking by Antiviral Oral Liquid Revenue
Table 3. Ranking of Global Top Antiviral Oral Liquid Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Antiviral Oral Liquid Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Syrup
Table 6. Key Players of Oral suspension
Table 7. Key Players of Oral solution
Table 8. Key Players of Oral drop
Table 9. Key Players of Oral emulsion
Table 10. Key Players of Mixture
Table 11. COVID-19 Impact Global Market: (Four Antiviral Oral Liquid Market Size Forecast Scenarios)
Table 12. Opportunities and Trends for Antiviral Oral Liquid Players in the COVID-19 Landscape
Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 14. Key Regions/Countries Measures against Covid-19 Impact
Table 15. Proposal for Antiviral Oral Liquid Players to Combat Covid-19 Impact
Table 16. Global Antiviral Oral Liquid Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 17. Global Antiviral Oral Liquid Market Size by Regions (US$ Million): 2020 VS 2026
Table 18. Global Antiviral Oral Liquid Market Size by Regions (2015-2020) (US$ Million)
Table 19. Global Antiviral Oral Liquid Market Share by Regions (2015-2020)
Table 20. Global Antiviral Oral Liquid Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 21. Global Antiviral Oral Liquid Market Share by Regions (2021-2026)
Table 22. Market Top Trends
Table 23. Key Drivers: Impact Analysis
Table 24. Key Challenges
Table 25. Antiviral Oral Liquid Market Growth Strategy
Table 26. Main Points Interviewed from Key Antiviral Oral Liquid Players
Table 27. Global Antiviral Oral Liquid Revenue by Players (2015-2020) (Million US$)
Table 28. Global Antiviral Oral Liquid Market Share by Players (2015-2020)
Table 29. Global Top Antiviral Oral Liquid Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiviral Oral Liquid as of 2019)
Table 30. Global Antiviral Oral Liquid by Players Market Concentration Ratio (CR5 and HHI)
Table 31. Key Players Headquarters and Area Served
Table 32. Key Players Antiviral Oral Liquid Product Solution and Service
Table 33. Date of Enter into Antiviral Oral Liquid Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Antiviral Oral Liquid Market Size by Type (2015-2020) (Million US$)
Table 36. Global Antiviral Oral Liquid Market Size Share by Type (2015-2020)
Table 37. Global Antiviral Oral Liquid Revenue Market Share by Type (2021-2026)
Table 38. Global Antiviral Oral Liquid Market Size Share by Application (2015-2020)
Table 39. Global Antiviral Oral Liquid Market Size by Application (2015-2020) (Million US$)
Table 40. Global Antiviral Oral Liquid Market Size Share by Application (2021-2026)
Table 41. North America Key Players Antiviral Oral Liquid Revenue (2019-2020) (Million US$)
Table 42. North America Key Players Antiviral Oral Liquid Market Share (2019-2020)
Table 43. North America Antiviral Oral Liquid Market Size by Type (2015-2020) (Million US$)
Table 44. North America Antiviral Oral Liquid Market Share by Type (2015-2020)
Table 45. North America Antiviral Oral Liquid Market Size by Application (2015-2020) (Million US$)
Table 46. North America Antiviral Oral Liquid Market Share by Application (2015-2020)
Table 47. Europe Key Players Antiviral Oral Liquid Revenue (2019-2020) (Million US$)
Table 48. Europe Key Players Antiviral Oral Liquid Market Share (2019-2020)
Table 49. Europe Antiviral Oral Liquid Market Size by Type (2015-2020) (Million US$)
Table 50. Europe Antiviral Oral Liquid Market Share by Type (2015-2020)
Table 51. Europe Antiviral Oral Liquid Market Size by Application (2015-2020) (Million US$)
Table 52. Europe Antiviral Oral Liquid Market Share by Application (2015-2020)
Table 53. China Key Players Antiviral Oral Liquid Revenue (2019-2020) (Million US$)
Table 54. China Key Players Antiviral Oral Liquid Market Share (2019-2020)
Table 55. China Antiviral Oral Liquid Market Size by Type (2015-2020) (Million US$)
Table 56. China Antiviral Oral Liquid Market Share by Type (2015-2020)
Table 57. China Antiviral Oral Liquid Market Size by Application (2015-2020) (Million US$)
Table 58. China Antiviral Oral Liquid Market Share by Application (2015-2020)
Table 59. Japan Key Players Antiviral Oral Liquid Revenue (2019-2020) (Million US$)
Table 60. Japan Key Players Antiviral Oral Liquid Market Share (2019-2020)
Table 61. Japan Antiviral Oral Liquid Market Size by Type (2015-2020) (Million US$)
Table 62. Japan Antiviral Oral Liquid Market Share by Type (2015-2020)
Table 63. Japan Antiviral Oral Liquid Market Size by Application (2015-2020) (Million US$)
Table 64. Japan Antiviral Oral Liquid Market Share by Application (2015-2020)
Table 65. Southeast Asia Key Players Antiviral Oral Liquid Revenue (2019-2020) (Million US$)
Table 66. Southeast Asia Key Players Antiviral Oral Liquid Market Share (2019-2020)
Table 67. Southeast Asia Antiviral Oral Liquid Market Size by Type (2015-2020) (Million US$)
Table 68. Southeast Asia Antiviral Oral Liquid Market Share by Type (2015-2020)
Table 69. Southeast Asia Antiviral Oral Liquid Market Size by Application (2015-2020) (Million US$)
Table 70. Southeast Asia Antiviral Oral Liquid Market Share by Application (2015-2020)
Table 71. India Key Players Antiviral Oral Liquid Revenue (2019-2020) (Million US$)
Table 72. India Key Players Antiviral Oral Liquid Market Share (2019-2020)
Table 73. India Antiviral Oral Liquid Market Size by Type (2015-2020) (Million US$)
Table 74. India Antiviral Oral Liquid Market Share by Type (2015-2020)
Table 75. India Antiviral Oral Liquid Market Size by Application (2015-2020) (Million US$)
Table 76. India Antiviral Oral Liquid Market Share by Application (2015-2020)
Table 77. Central & South America Key Players Antiviral Oral Liquid Revenue (2019-2020) (Million US$)
Table 78. Central & South America Key Players Antiviral Oral Liquid Market Share (2019-2020)
Table 79. Central & South America Antiviral Oral Liquid Market Size by Type (2015-2020) (Million US$)
Table 80. Central & South America Antiviral Oral Liquid Market Share by Type (2015-2020)
Table 81. Central & South America Antiviral Oral Liquid Market Size by Application (2015-2020) (Million US$)
Table 82. Central & South America Antiviral Oral Liquid Market Share by Application (2015-2020)
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Product
Table 86. Pfizer Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$)
Table 87. Pfizer Recent Development
Table 88. Roche Company Details
Table 89. Roche Business Overview
Table 90. Roche Product
Table 91. Roche Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$)
Table 92. Roche Recent Development
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Product
Table 96. Novartis Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$)
Table 97. Novartis Recent Development
Table 98. Merck Company Details
Table 99. Merck Business Overview
Table 100. Merck Product
Table 101. Merck Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$)
Table 102. Merck Recent Development
Table 103. GlaxoSmithKline Company Details
Table 104. GlaxoSmithKline Business Overview
Table 105. GlaxoSmithKline Product
Table 106. GlaxoSmithKline Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$)
Table 107. GlaxoSmithKline Recent Development
Table 108. Johnson & Johnson Company Details
Table 109. Johnson & Johnson Business Overview
Table 110. Johnson & Johnson Product
Table 111. Johnson & Johnson Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$)
Table 112. Johnson & Johnson Recent Development
Table 113. AbbVie Company Details
Table 114. AbbVie Business Overview
Table 115. AbbVie Product
Table 116. AbbVie Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$)
Table 117. AbbVie Recent Development
Table 118. Sanofi Business Overview
Table 119. Sanofi Product
Table 120. Sanofi Company Details
Table 121. Sanofi Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$)
Table 122. Sanofi Recent Development
Table 123. Bristol-Myers Squibb Company Details
Table 124. Bristol-Myers Squibb Business Overview
Table 125. Bristol-Myers Squibb Product
Table 126. Bristol-Myers Squibb Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$)
Table 127. Bristol-Myers Squibb Recent Development
Table 128. AstraZeneca Company Details
Table 129. AstraZeneca Business Overview
Table 130. AstraZeneca Product
Table 131. AstraZeneca Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$)
Table 132. AstraZeneca Recent Development
Table 133. Eli Lilly Company Details
Table 134. Eli Lilly Business Overview
Table 135. Eli Lilly Product
Table 136. Eli Lilly Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$)
Table 137. Eli Lilly Recent Development
Table 138. Novo Nordisk Company Details
Table 139. Novo Nordisk Business Overview
Table 140. Novo Nordisk Product
Table 141. Novo Nordisk Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$)
Table 142. Novo Nordisk Recent Development
Table 143. Amgen Company Details
Table 144. Amgen Business Overview
Table 145. Amgen Product
Table 146. Amgen Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$)
Table 147. Amgen Recent Development
Table 148. Gilead Sciences Company Details
Table 149. Gilead Sciences Business Overview
Table 150. Gilead Sciences Product
Table 151. Gilead Sciences Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$)
Table 152. Gilead Sciences Recent Development
Table 153. CSL Company Details
Table 154. CSL Business Overview
Table 155. CSL Product
Table 156. CSL Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$)
Table 157. CSL Recent Development
Table 158. Takeda Pharmaceuticals Company Details
Table 159. Takeda Pharmaceuticals Business Overview
Table 160. Takeda Pharmaceuticals Product
Table 161. Takeda Pharmaceuticals Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$)
Table 162. Takeda Pharmaceuticals Recent Development
Table 163. Bayer Company Details
Table 164. Bayer Business Overview
Table 165. Bayer Product
Table 166. Bayer Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$)
Table 167. Bayer Recent Development
Table 168. Celgene Company Details
Table 169. Celgene Business Overview
Table 170. Celgene Product
Table 171. Celgene Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$)
Table 172. Celgene Recent Development
Table 173. Merck KGaA Company Details
Table 174. Merck KGaA Business Overview
Table 175. Merck KGaA Product
Table 176. Merck KGaA Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$)
Table 177. Merck KGaA Recent Development
Table 178. Allergan Company Details
Table 179. Allergan Business Overview
Table 180. Allergan Product
Table 181. Allergan Revenue in Antiviral Oral Liquid Business (2015-2020) (Million US$)
Table 182. Allergan Recent Development
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Antiviral Oral Liquid Market Share by Type: 2020 VS 2026
Figure 2. Syrup Features
Figure 3. Oral suspension Features
Figure 4. Oral solution Features
Figure 5. Oral drop Features
Figure 6. Oral emulsion Features
Figure 7. Mixture Features
Figure 8. Global Antiviral Oral Liquid Market Share by Application: 2020 VS 2026
Figure 9. Adults Case Studies
Figure 10. Children Case Studies
Figure 11. Antiviral Oral Liquid Report Years Considered
Figure 12. Global Antiviral Oral Liquid Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Antiviral Oral Liquid Market Share by Regions: 2020 VS 2026
Figure 14. Global Antiviral Oral Liquid Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Antiviral Oral Liquid Market Share by Players in 2019
Figure 17. Global Top Antiviral Oral Liquid Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiviral Oral Liquid as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Antiviral Oral Liquid Revenue in 2019
Figure 19. North America Antiviral Oral Liquid Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Antiviral Oral Liquid Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Antiviral Oral Liquid Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Antiviral Oral Liquid Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Antiviral Oral Liquid Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Antiviral Oral Liquid Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Antiviral Oral Liquid Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Pfizer Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020)
Figure 28. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Roche Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020)
Figure 30. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Novartis Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020)
Figure 32. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Merck Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020)
Figure 34. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. GlaxoSmithKline Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020)
Figure 36. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Johnson & Johnson Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020)
Figure 38. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. AbbVie Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020)
Figure 40. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Sanofi Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020)
Figure 42. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Bristol-Myers Squibb Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020)
Figure 44. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. AstraZeneca Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020)
Figure 46. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Eli Lilly Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020)
Figure 48. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Novo Nordisk Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020)
Figure 50. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Amgen Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020)
Figure 52. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Gilead Sciences Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020)
Figure 54. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. CSL Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020)
Figure 56. Takeda Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Takeda Pharmaceuticals Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020)
Figure 58. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Bayer Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020)
Figure 60. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Celgene Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020)
Figure 62. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Merck KGaA Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020)
Figure 64. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Allergan Revenue Growth Rate in Antiviral Oral Liquid Business (2015-2020)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed